VYNE

Conviction 50HealthcareScan · Fri, Jun 26, 2026

VYNE$0.6600+1.27%

ResistanceSupportVol 14

Vol MA14 122.53K

Mar 27Apr 15May 4May 20Jun 9Jun 26

VYNE Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.vynetherapeutics.com ↗

Price0.6600

Change+1.27%

Gap-0.23%

Rel volume0.52×

Avg volume115.04K

Avg $ vol74.53K

SMA 200.6552

SMA 500.6564

SMA 2000.5248

Price vs 50+0.55%

Price vs 200+25.77%

MA stackbullish

50/200 cross—

Supertrenddown · 0.7113

RSI (14)53

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D75 / 66

ADX (14)35

+DI / −DI11 / 24

RSI divergence—

MACD divergence—

ATR %+3.95%

ADR %4.12%

52w high1.77

52w low0.2870

From 52w high-62.71%

Above 52w low+129.97%

New 52w highNo

SqueezeOn · 1d

Bollinger width9.74%

%B0.58

Donchian pos62.58%

Donchian high0.6899

Donchian low0.6100

AVWAP (52w high)0.5418

vs AVWAP high+21.82%

AVWAP (52w low)0.5494

vs AVWAP low+20.12%

OBV trendFlat

Chaikin MF (20)-0.29

Today vs 20d0.52×

Avg vol (14d)122.53K

Avg vol (20d)115.04K

Avg $ vol (20d)74.53K

Market cap—

RS 3m (vs SPY)-6.02%

RS 6m (vs SPY)+5.98%

RS line new highNo

Trend template6/8

Technical rank67.4

1 week+3.87%

1 month-2.93%

3 months+6.88%

6 months+16.12%

1 year-51.82%

YTD+13.81%

P/E-0.83

P/B0.90

P/S38.77

P/FCF-0.67

EPS-0.6200

Div yield—

ROE-107.49%

ROA-102.36%

Debt/Eq0.00

Current20.86

EV/EBITDA0.09

Gross margin—

Net margin—

Rev growth13.77%

EPS growth33.52%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-2.53M

Revenue86K

Net income-3.58M

Gross profit—

Free cash flow-33.12M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out33.35M

Employees10

ListedThu, Jan 25, 2018

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction50 / 100

Pattern quality—

Tech rank67.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.6880

Support0.6165

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VYNE

All disclosures →

No recent disclosed trades by Congress in VYNE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VYNE · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Domzalski David PRESIDENT AND CEO · Common Stock · 2026-05-29	Grant	30.79K	$10K	2026-05-29	2026-06-02

SEC filings

EDGAR filings in VYNE · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.